About Brian Feth
Form D filings for Xcell Biosciences from 2017 to 2024 list Brian Feth as chief executive officer and director.
Brian Feth first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Brian Feth in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Brian Feth works with at each company, as listed on that company's latest Form D.
Xcell Biosciences, Inc. · Form D, Dec 17, 2024